Global and Japan Chorionic Gonadotrophin Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Dec-2021
No. of pages: 155
Inquire Before Buying

Chorionic Gonadotrophin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chorionic Gonadotrophin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Chorionic Gonadotrophin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- 500U

- 1000U

- 2000U

- 3000U

- 5000U

Segment by Application

- Undescended Testicles In Adolescence

- Male Infertility

- Female Anovulatory Infertility

- In Vitro Fertilization

- Abortion

- Functional Uterine Hemorrhage

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merck Serono

- Bristol Myers Squibb

- Ferring

- Fresenius Kabi

- Sun Pharmaceutical

- Besins Healthcare Benelux

- Jean-Marie

- Organon

- Hubei Dongxin Pharmaceutical

- Changchun Jinsai Pharmaceutical

- Ningbo Renjian Pharmaceutical Group

- Yantai Dongcheng North Pharmaceutical

- Maanshan Fengyuan Pharmaceutical

- Sinopharm

- Livzon Pharmaceutical Group

- Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Global and Japan Chorionic Gonadotrophin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Chorionic Gonadotrophin Product Introduction
1.2 Market by Type
1.2.1 Global Chorionic Gonadotrophin Market Size Growth Rate by Type
1.2.2 500U
1.2.3 1000U
1.2.4 2000U
1.2.5 3000U
1.2.6 5000U
1.3 Market by Application
1.3.1 Global Chorionic Gonadotrophin Market Size Growth Rate by Application
1.3.2 Undescended Testicles In Adolescence
1.3.3 Male Infertility
1.3.4 Female Anovulatory Infertility
1.3.5 In Vitro Fertilization
1.3.6 Abortion
1.3.7 Functional Uterine Hemorrhage
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chorionic Gonadotrophin Market Size, Estimates and Forecasts
2.1.1 Global Chorionic Gonadotrophin Revenue 2016-2027
2.1.2 Global Chorionic Gonadotrophin Sales 2016-2027
2.2 Global Chorionic Gonadotrophin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Chorionic Gonadotrophin Historical Market Size by Region (2016-2021)
2.3.1 Global Chorionic Gonadotrophin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Chorionic Gonadotrophin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Chorionic Gonadotrophin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Chorionic Gonadotrophin Sales Forecast by Region (2022-2027)
2.4.2 Global Chorionic Gonadotrophin Revenue Forecast by Region (2022-2027)
3 Global Chorionic Gonadotrophin Competitor Landscape by Players
3.1 Global Top Chorionic Gonadotrophin Manufacturers by Sales
3.1.1 Global Chorionic Gonadotrophin Sales by Manufacturer (2016-2021)
3.1.2 Global Chorionic Gonadotrophin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Chorionic Gonadotrophin Manufacturers by Revenue
3.2.1 Key Chorionic Gonadotrophin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Chorionic Gonadotrophin Revenue by Manufacturers (2016-2021)
3.2.3 Global Chorionic Gonadotrophin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Chorionic Gonadotrophin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Chorionic Gonadotrophin Revenue in 2020
3.2.6 Global Chorionic Gonadotrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chorionic Gonadotrophin Price by Manufacturers
3.4 Global Chorionic Gonadotrophin Manufacturing Base Distribution, Product Types
3.4.1 Chorionic Gonadotrophin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chorionic Gonadotrophin Product Type
3.4.3 Date of International Manufacturers Enter into Chorionic Gonadotrophin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Chorionic Gonadotrophin Market Size by Type (2016-2021)
4.1.1 Global Chorionic Gonadotrophin Sales by Type (2016-2021)
4.1.2 Global Chorionic Gonadotrophin Revenue by Type (2016-2021)
4.1.3 Chorionic Gonadotrophin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Chorionic Gonadotrophin Market Size Forecast by Type (2022-2027)
4.2.1 Global Chorionic Gonadotrophin Sales Forecast by Type (2022-2027)
4.2.2 Global Chorionic Gonadotrophin Revenue Forecast by Type (2022-2027)
4.2.3 Chorionic Gonadotrophin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Chorionic Gonadotrophin Market Size by Application (2016-2021)
5.1.1 Global Chorionic Gonadotrophin Sales by Application (2016-2021)
5.1.2 Global Chorionic Gonadotrophin Revenue by Application (2016-2021)
5.1.3 Chorionic Gonadotrophin Price by Application (2016-2021)
5.2 Chorionic Gonadotrophin Market Size Forecast by Application (2022-2027)
5.2.1 Global Chorionic Gonadotrophin Sales Forecast by Application (2022-2027)
5.2.2 Global Chorionic Gonadotrophin Revenue Forecast by Application (2022-2027)
5.2.3 Global Chorionic Gonadotrophin Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
6.1.1 Japan Chorionic Gonadotrophin Sales YoY Growth 2016-2027
6.1.2 Japan Chorionic Gonadotrophin Revenue YoY Growth 2016-2027
6.1.3 Japan Chorionic Gonadotrophin Market Share in Global Market 2016-2027
6.2 Japan Chorionic Gonadotrophin Market Size by Players (International and Local Players)
6.2.1 Japan Top Chorionic Gonadotrophin Players by Sales (2016-2021)
6.2.2 Japan Top Chorionic Gonadotrophin Players by Revenue (2016-2021)
6.3 Japan Chorionic Gonadotrophin Historic Market Review by Type (2016-2021)
6.3.1 Japan Chorionic Gonadotrophin Sales Market Share by Type (2016-2021)
6.3.2 Japan Chorionic Gonadotrophin Revenue Market Share by Type (2016-2021)
6.3.3 Japan Chorionic Gonadotrophin Price by Type (2016-2021)
6.4 Japan Chorionic Gonadotrophin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Chorionic Gonadotrophin Sales Forecast by Type (2022-2027)
6.4.2 Japan Chorionic Gonadotrophin Revenue Forecast by Type (2022-2027)
6.4.3 Japan Chorionic Gonadotrophin Price Forecast by Type (2022-2027)
6.5 Japan Chorionic Gonadotrophin Historic Market Review by Application (2016-2021)
6.5.1 Japan Chorionic Gonadotrophin Sales Market Share by Application (2016-2021)
6.5.2 Japan Chorionic Gonadotrophin Revenue Market Share by Application (2016-2021)
6.5.3 Japan Chorionic Gonadotrophin Price by Application (2016-2021)
6.6 Japan Chorionic Gonadotrophin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Chorionic Gonadotrophin Sales Forecast by Application (2022-2027)
6.6.2 Japan Chorionic Gonadotrophin Revenue Forecast by Application (2022-2027)
6.6.3 Japan Chorionic Gonadotrophin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
7.2 North America Chorionic Gonadotrophin Market Facts & Figures by Country
7.2.1 North America Chorionic Gonadotrophin Sales by Country (2016-2021)
7.2.2 North America Chorionic Gonadotrophin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Chorionic Gonadotrophin Market Facts & Figures by Region
8.2.1 Asia Pacific Chorionic Gonadotrophin Sales by Region (2016-2021)
8.2.2 Asia Pacific Chorionic Gonadotrophin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
9.2 Europe Chorionic Gonadotrophin Market Facts & Figures by Country
9.2.1 Europe Chorionic Gonadotrophin Sales by Country (2016-2021)
9.2.2 Europe Chorionic Gonadotrophin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
10.2 Latin America Chorionic Gonadotrophin Market Facts & Figures by Country
10.2.1 Latin America Chorionic Gonadotrophin Sales by Country (2016-2021)
10.2.2 Latin America Chorionic Gonadotrophin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chorionic Gonadotrophin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Chorionic Gonadotrophin Market Facts & Figures by Country
11.2.1 Middle East and Africa Chorionic Gonadotrophin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Chorionic Gonadotrophin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Merck Serono
12.1.1 Merck Serono Corporation Information
12.1.2 Merck Serono Description and Business Overview
12.1.3 Merck Serono Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Serono Chorionic Gonadotrophin Products Offered
12.1.5 Merck Serono Recent Development
12.2 Bristol Myers Squibb
12.2.1 Bristol Myers Squibb Corporation Information
12.2.2 Bristol Myers Squibb Description and Business Overview
12.2.3 Bristol Myers Squibb Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bristol Myers Squibb Chorionic Gonadotrophin Products Offered
12.2.5 Bristol Myers Squibb Recent Development
12.3 Ferring
12.3.1 Ferring Corporation Information
12.3.2 Ferring Description and Business Overview
12.3.3 Ferring Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Ferring Chorionic Gonadotrophin Products Offered
12.3.5 Ferring Recent Development
12.4 Fresenius Kabi
12.4.1 Fresenius Kabi Corporation Information
12.4.2 Fresenius Kabi Description and Business Overview
12.4.3 Fresenius Kabi Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fresenius Kabi Chorionic Gonadotrophin Products Offered
12.4.5 Fresenius Kabi Recent Development
12.5 Sun Pharmaceutical
12.5.1 Sun Pharmaceutical Corporation Information
12.5.2 Sun Pharmaceutical Description and Business Overview
12.5.3 Sun Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sun Pharmaceutical Chorionic Gonadotrophin Products Offered
12.5.5 Sun Pharmaceutical Recent Development
12.6 Besins Healthcare Benelux
12.6.1 Besins Healthcare Benelux Corporation Information
12.6.2 Besins Healthcare Benelux Description and Business Overview
12.6.3 Besins Healthcare Benelux Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Besins Healthcare Benelux Chorionic Gonadotrophin Products Offered
12.6.5 Besins Healthcare Benelux Recent Development
12.7 Jean-Marie
12.7.1 Jean-Marie Corporation Information
12.7.2 Jean-Marie Description and Business Overview
12.7.3 Jean-Marie Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Jean-Marie Chorionic Gonadotrophin Products Offered
12.7.5 Jean-Marie Recent Development
12.8 Organon
12.8.1 Organon Corporation Information
12.8.2 Organon Description and Business Overview
12.8.3 Organon Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Organon Chorionic Gonadotrophin Products Offered
12.8.5 Organon Recent Development
12.9 Hubei Dongxin Pharmaceutical
12.9.1 Hubei Dongxin Pharmaceutical Corporation Information
12.9.2 Hubei Dongxin Pharmaceutical Description and Business Overview
12.9.3 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Products Offered
12.9.5 Hubei Dongxin Pharmaceutical Recent Development
12.10 Changchun Jinsai Pharmaceutical
12.10.1 Changchun Jinsai Pharmaceutical Corporation Information
12.10.2 Changchun Jinsai Pharmaceutical Description and Business Overview
12.10.3 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Products Offered
12.10.5 Changchun Jinsai Pharmaceutical Recent Development
12.11 Merck Serono
12.11.1 Merck Serono Corporation Information
12.11.2 Merck Serono Description and Business Overview
12.11.3 Merck Serono Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Serono Chorionic Gonadotrophin Products Offered
12.11.5 Merck Serono Recent Development
12.12 Yantai Dongcheng North Pharmaceutical
12.12.1 Yantai Dongcheng North Pharmaceutical Corporation Information
12.12.2 Yantai Dongcheng North Pharmaceutical Description and Business Overview
12.12.3 Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Yantai Dongcheng North Pharmaceutical Products Offered
12.12.5 Yantai Dongcheng North Pharmaceutical Recent Development
12.13 Maanshan Fengyuan Pharmaceutical
12.13.1 Maanshan Fengyuan Pharmaceutical Corporation Information
12.13.2 Maanshan Fengyuan Pharmaceutical Description and Business Overview
12.13.3 Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Maanshan Fengyuan Pharmaceutical Products Offered
12.13.5 Maanshan Fengyuan Pharmaceutical Recent Development
12.14 Sinopharm
12.14.1 Sinopharm Corporation Information
12.14.2 Sinopharm Description and Business Overview
12.14.3 Sinopharm Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sinopharm Products Offered
12.14.5 Sinopharm Recent Development
12.15 Livzon Pharmaceutical Group
12.15.1 Livzon Pharmaceutical Group Corporation Information
12.15.2 Livzon Pharmaceutical Group Description and Business Overview
12.15.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Livzon Pharmaceutical Group Products Offered
12.15.5 Livzon Pharmaceutical Group Recent Development
12.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
12.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
12.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
12.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Products Offered
12.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Chorionic Gonadotrophin Industry Trends
13.2 Chorionic Gonadotrophin Market Drivers
13.3 Chorionic Gonadotrophin Market Challenges
13.4 Chorionic Gonadotrophin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chorionic Gonadotrophin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Chorionic Gonadotrophin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 500U
Table 3. Major Manufacturers of 1000U
Table 4. Major Manufacturers of 2000U
Table 5. Major Manufacturers of 3000U
Table 6. Major Manufacturers of 5000U
Table 7. Global Chorionic Gonadotrophin Market Size Growth Rate by Application (2021-2027) & (KG)
Table 8. Global Chorionic Gonadotrophin Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Chorionic Gonadotrophin Sales by Regions (2016-2021) & (KG)
Table 10. Global Chorionic Gonadotrophin Sales Market Share by Regions (2016-2021)
Table 11. Global Chorionic Gonadotrophin Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Chorionic Gonadotrophin Sales Forecast by Region (2022-2027) & (KG)
Table 13. Global Chorionic Gonadotrophin Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Chorionic Gonadotrophin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Chorionic Gonadotrophin Sales by Manufacturers (2016-2021) (KG)
Table 17. Global Chorionic Gonadotrophin Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Chorionic Gonadotrophin Manufacturers by Revenue (US$ Million) in 2020
Table 19. Chorionic Gonadotrophin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Chorionic Gonadotrophin Revenue Share by Manufacturers (2016-2021)
Table 21. Global Chorionic Gonadotrophin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Chorionic Gonadotrophin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chorionic Gonadotrophin as of 2020)
Table 23. Key Manufacturers Chorionic Gonadotrophin Price (2016-2021) (US$/G)
Table 24. Chorionic Gonadotrophin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Chorionic Gonadotrophin Product Type
Table 26. Date of International Manufacturers Enter into Chorionic Gonadotrophin Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Chorionic Gonadotrophin Sales by Type (2016-2021) (KG)
Table 29. Global Chorionic Gonadotrophin Sales Share by Type (2016-2021)
Table 30. Global Chorionic Gonadotrophin Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Chorionic Gonadotrophin Revenue Share by Type (2016-2021)
Table 32. Chorionic Gonadotrophin Average Selling Price (ASP) by Type (2016-2021) & (US$/G)
Table 33. Global Chorionic Gonadotrophin Sales Forecast by Type (2022-2027) & (KG)
Table 34. Global Chorionic Gonadotrophin Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Chorionic Gonadotrophin Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Chorionic Gonadotrophin Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G)
Table 38. Global Chorionic Gonadotrophin Sales by Application (2016-2021) (KG)
Table 39. Global Chorionic Gonadotrophin Sales Share by Application (2016-2021)
Table 40. Global Chorionic Gonadotrophin Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Chorionic Gonadotrophin Revenue Share by Application (2016-2021)
Table 42. Chorionic Gonadotrophin Average Selling Price (ASP) by Application (2016-2021) & (US$/G)
Table 43. Global Chorionic Gonadotrophin Sales Forecast by Application (2022-2027) & (KG)
Table 44. Global Chorionic Gonadotrophin Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Chorionic Gonadotrophin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Chorionic Gonadotrophin Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Chorionic Gonadotrophin Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G)
Table 48. Japan Chorionic Gonadotrophin Sales (KG) of Key Companies (2016-2021)
Table 49. Japan Chorionic Gonadotrophin Sales Share by Company (2016-2021)
Table 50. Japan Chorionic Gonadotrophin Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Chorionic Gonadotrophin Revenue Share by Company (2016-2021)
Table 52. Japan Chorionic Gonadotrophin Sales (KG) by Type (2016-2021)
Table 53. Japan Chorionic Gonadotrophin Sales Share by Type (2016-2021)
Table 54. Japan Chorionic Gonadotrophin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Chorionic Gonadotrophin Price (US$/G) by Type (2016-2021)
Table 56. Japan Chorionic Gonadotrophin Sales (KG) by Type (2022-2027)
Table 57. Japan Chorionic Gonadotrophin Sales Share by Type (2022-2027)
Table 58. Japan Chorionic Gonadotrophin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Chorionic Gonadotrophin Revenue Share by Type (2022-2027)
Table 60. Japan Chorionic Gonadotrophin Price (US$/G) by Type (2022-2027)
Table 61. Japan Chorionic Gonadotrophin Sales (KG) by Application (2016-2021)
Table 62. Japan Chorionic Gonadotrophin Sales Share by Application (2016-2021)
Table 63. Japan Chorionic Gonadotrophin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Chorionic Gonadotrophin Price (US$/G) by Application (2016-2021)
Table 65. Japan Chorionic Gonadotrophin Sales (KG) by Application (2022-2027)
Table 66. Japan Chorionic Gonadotrophin Sales Share by Application (2022-2027)
Table 67. Japan Chorionic Gonadotrophin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Chorionic Gonadotrophin Revenue Share by Application (2022-2027)
Table 69. Japan Chorionic Gonadotrophin Price (US$/G) by Application (2022-2027)
Table 70. North America Chorionic Gonadotrophin Sales by Country (2016-2021) & (KG)
Table 71. North America Chorionic Gonadotrophin Sales Market Share by Country (2016-2021)
Table 72. North America Chorionic Gonadotrophin Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Chorionic Gonadotrophin Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Chorionic Gonadotrophin Sales by Region (2016-2021) & (KG)
Table 75. Asia Pacific Chorionic Gonadotrophin Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Chorionic Gonadotrophin Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Chorionic Gonadotrophin Revenue Market Share by Region (2016-2021)
Table 78. Europe Chorionic Gonadotrophin Sales by Country (2016-2021) & (KG)
Table 79. Europe Chorionic Gonadotrophin Sales Market Share by Country (2016-2021)
Table 80. Europe Chorionic Gonadotrophin Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Chorionic Gonadotrophin Revenue Market Share by Country (2016-2021)
Table 82. Latin America Chorionic Gonadotrophin Sales by Country (2016-2021) & (KG)
Table 83. Latin America Chorionic Gonadotrophin Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Chorionic Gonadotrophin Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Chorionic Gonadotrophin Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Chorionic Gonadotrophin Sales by Country (2016-2021) & (KG)
Table 87. Middle East and Africa Chorionic Gonadotrophin Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Chorionic Gonadotrophin Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Chorionic Gonadotrophin Revenue Market Share by Country (2016-2021)
Table 90. Merck Serono Corporation Information
Table 91. Merck Serono Description and Business Overview
Table 92. Merck Serono Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 93. Merck Serono Chorionic Gonadotrophin Product
Table 94. Merck Serono Recent Development
Table 95. Bristol Myers Squibb Corporation Information
Table 96. Bristol Myers Squibb Description and Business Overview
Table 97. Bristol Myers Squibb Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 98. Bristol Myers Squibb Product
Table 99. Bristol Myers Squibb Recent Development
Table 100. Ferring Corporation Information
Table 101. Ferring Description and Business Overview
Table 102. Ferring Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 103. Ferring Product
Table 104. Ferring Recent Development
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 108. Fresenius Kabi Product
Table 109. Fresenius Kabi Recent Development
Table 110. Sun Pharmaceutical Corporation Information
Table 111. Sun Pharmaceutical Description and Business Overview
Table 112. Sun Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 113. Sun Pharmaceutical Product
Table 114. Sun Pharmaceutical Recent Development
Table 115. Besins Healthcare Benelux Corporation Information
Table 116. Besins Healthcare Benelux Description and Business Overview
Table 117. Besins Healthcare Benelux Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 118. Besins Healthcare Benelux Product
Table 119. Besins Healthcare Benelux Recent Development
Table 120. Jean-Marie Corporation Information
Table 121. Jean-Marie Description and Business Overview
Table 122. Jean-Marie Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 123. Jean-Marie Product
Table 124. Jean-Marie Recent Development
Table 125. Organon Corporation Information
Table 126. Organon Description and Business Overview
Table 127. Organon Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 128. Organon Product
Table 129. Organon Recent Development
Table 130. Hubei Dongxin Pharmaceutical Corporation Information
Table 131. Hubei Dongxin Pharmaceutical Description and Business Overview
Table 132. Hubei Dongxin Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 133. Hubei Dongxin Pharmaceutical Product
Table 134. Hubei Dongxin Pharmaceutical Recent Development
Table 135. Changchun Jinsai Pharmaceutical Corporation Information
Table 136. Changchun Jinsai Pharmaceutical Description and Business Overview
Table 137. Changchun Jinsai Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 138. Changchun Jinsai Pharmaceutical Product
Table 139. Changchun Jinsai Pharmaceutical Recent Development
Table 140. Ningbo Renjian Pharmaceutical Group Corporation Information
Table 141. Ningbo Renjian Pharmaceutical Group Description and Business Overview
Table 142. Ningbo Renjian Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 143. Ningbo Renjian Pharmaceutical Group Product
Table 144. Ningbo Renjian Pharmaceutical Group Recent Development
Table 145. Yantai Dongcheng North Pharmaceutical Corporation Information
Table 146. Yantai Dongcheng North Pharmaceutical Description and Business Overview
Table 147. Yantai Dongcheng North Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 148. Yantai Dongcheng North Pharmaceutical Product
Table 149. Yantai Dongcheng North Pharmaceutical Recent Development
Table 150. Maanshan Fengyuan Pharmaceutical Corporation Information
Table 151. Maanshan Fengyuan Pharmaceutical Description and Business Overview
Table 152. Maanshan Fengyuan Pharmaceutical Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 153. Maanshan Fengyuan Pharmaceutical Product
Table 154. Maanshan Fengyuan Pharmaceutical Recent Development
Table 155. Sinopharm Corporation Information
Table 156. Sinopharm Description and Business Overview
Table 157. Sinopharm Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 158. Sinopharm Product
Table 159. Sinopharm Recent Development
Table 160. Livzon Pharmaceutical Group Corporation Information
Table 161. Livzon Pharmaceutical Group Description and Business Overview
Table 162. Livzon Pharmaceutical Group Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 163. Livzon Pharmaceutical Group Product
Table 164. Livzon Pharmaceutical Group Recent Development
Table 165. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
Table 166. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
Table 167. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Chorionic Gonadotrophin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 168. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Product
Table 169. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 170. Chorionic Gonadotrophin Market Trends
Table 171. Chorionic Gonadotrophin Market Drivers
Table 172. Chorionic Gonadotrophin Market Challenges
Table 173. Chorionic Gonadotrophin Market Restraints
Table 174. Chorionic Gonadotrophin Customers List
Table 175. Chorionic Gonadotrophin Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Chorionic Gonadotrophin Product Picture
Figure 2. Global Chorionic Gonadotrophin Sales Market Share by Type in 2020 & 2027
Figure 3. 500U Product Picture
Figure 4. 1000U Product Picture
Figure 5. 2000U Product Picture
Figure 6. 3000U Product Picture
Figure 7. 5000U Product Picture
Figure 8. Global Chorionic Gonadotrophin Sales Market Share by Application in 2020 & 2027
Figure 9. Undescended Testicles In Adolescence
Figure 10. Male Infertility
Figure 11. Female Anovulatory Infertility
Figure 12. In Vitro Fertilization
Figure 13. Abortion
Figure 14. Functional Uterine Hemorrhage
Figure 15. Other
Figure 16. Chorionic Gonadotrophin Report Years Considered
Figure 17. Global Chorionic Gonadotrophin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Chorionic Gonadotrophin Market Size 2016-2027 (US$ Million)
Figure 19. Global Chorionic Gonadotrophin Sales 2016-2027 (KG)
Figure 20. Global Chorionic Gonadotrophin Market Size Market Share by Region: 2021 Versus 2027
Figure 21. Global Chorionic Gonadotrophin Sales Market Share by Region (2016-2021)
Figure 22. Global Chorionic Gonadotrophin Sales Market Share by Region in 2020
Figure 23. Global Chorionic Gonadotrophin Revenue Market Share by Region (2016-2021)
Figure 24. Global Chorionic Gonadotrophin Revenue Market Share by Region in 2020
Figure 25. Global Chorionic Gonadotrophin Sales Share by Manufacturer in 2020
Figure 26. The Top 10 and 5 Players Market Share by Chorionic Gonadotrophin Revenue in 2020
Figure 27. Chorionic Gonadotrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Chorionic Gonadotrophin Sales Market Share by Type (2016-2021)
Figure 29. Global Chorionic Gonadotrophin Sales Market Share by Type in 2020
Figure 30. Global Chorionic Gonadotrophin R
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs